EXO EXOR N.V.

Clarivate and Exor sign agreement

Clarivate and Exor sign agreement

Clarivate and Exor Sign Agreement Under Which Suzanne Heywood Will Be Nominated to Stand for Election to the Company’s Board of Directors

Exor becomes a long-term investor in Clarivate, endorsing the strategic direction set out by the Company’s Management and Board, and announces it now has a 10.1% shareholding in the Company and can increase its participation up to 17.5%

London, U.K., and Amsterdam, the Netherlands, March 4, 2024 – (NYSE: CLVT), a leading global provider of transformative intelligence and (AEX:EXO), the Netherlands-based diversified holding company, today announced that Suzanne Heywood will be nominated for election to the Clarivate Board of Directors at the Company’s next Annual General Meeting of shareholders on May 7, 2024. Under the terms of the agreement, Exor, which now owns 10.1% of Clarivate, may increase its participation up to 17.5% of Clarivate’s outstanding ordinary share capital.

Jonathan Gear, CEO, Clarivate said: “We welcome Exor’s commitment to our strategy as a long-term investor. I’m encouraged by their vote of confidence that conveys faith in our abilities to deliver solutions that our customers trust to fuel the world’s greatest breakthroughs.”

Andy Snyder, Chairman of the Board, Clarivate, commented: “We look forward to Suzanne joining the Board. She will bring tremendous in-depth experience from multiple Board roles for large global corporations and her guidance will be invaluable as we continue to transform Clarivate into a world-leading intelligence provider.”

Suzanne Heywood said, “We are delighted to be a shareholder of Clarivate, a global provider of data, analytics, technology and expert services to several sectors including healthcare. By bringing our experience of building great companies to the board level, we look forward to help Clarivate achieve ambitious goals and express its full potential.”

Suzanne Heywood is the COO of Exor and the Chair of CNH Industrial N.V. and Iveco Group. She was born in Southampton, England and has a Science MA from Oxford University and PhD from Cambridge University that she gained after a childhood spent sailing around the world on a boat. Suzanne started her professional career in the UK Treasury. In 1997, she joined McKinsey & Company where she held increasingly senior positions including, as a Senior Partner, co-leading McKinsey’s global service line on operating model change. Suzanne is also a Board member of The Economist and Louboutin.

# # #

About Clarivate

Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit .com

About Exor

Exor N.V. (AEX: EXO), is a diversified holding company that is based in the Netherlands and listed on the AEX. For over a century, Exor has built great companies and made successful investments worldwide, applying a culture that combines entrepreneurial spirit and financial discipline. Its portfolio is principally made up of companies in which Exor is the largest shareholder including Ferrari, Stellantis, CNH Industrial and Philips. For more information, please visit

Media contacts

-

Attachment



EN
04/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EXOR N.V.

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Alfen: Production resumed in mid-April, cost hit €5m. Exor: Read-across from Philips personal injury settlement. Philips: 1Q24 results – settlement reached. Recticel: 1Q24 in line with expectations. Sofina: Exit Petit Forestier

 PRESS RELEASE

Exor Press Release - Periodic Report on the Buyback Program

Exor Press Release - Periodic Report on the Buyback Program Amsterdam, 29 April 2024 EXOR N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM Exor N.V. (AMS: EXO) (“Exor” or the “Company”) announces that, under the first tranche of the share buyback program of up to €125 million announced on 15 April 2024 (the “first tranche”), the Company has completed the following transactions on Euronext Amsterdam and CBOE DXE: EURONEXT AMSTERDAM Trading DateNumber of ordinary shares purchasedAverage price per share excluding fees (€)Total consideration excluding fees (€)22 April 202417,677100.551,77...

 PRESS RELEASE

Exor Press Release - Periodic Report on the Buyback Program

Exor Press Release - Periodic Report on the Buyback Program Amsterdam, 22 April 2024 EXOR N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM Exor N.V. (AMS: EXO) (“Exor” or the “Company”) announces that, under the first tranche of the share buyback program of up to €125 million announced on 15 April 2024 (the “first tranche”), the Company has completed the following transactions on Euronext Amsterdam and CBOE DXE: EURONEXT AMSTERDAM Trading DateNumber of ordinary shares purchasedAverage price per share excluding fees (€)Total consideration excluding fees (€)15 April 202416,834101.081,701,535.2...

 PRESS RELEASE

Exor Press Release - Restart of Announced Share Buyback Program

Exor Press Release - Restart of Announced Share Buyback Program                                                                        Amsterdam, 15 April 2024 EXOR N.V. ANNOUNCES THE RESTART OF THE ANNOUNCED SHARE BUYBACK PROGRAM Exor N.V. (the “Company”) announces today that it will restart the share buyback program announced on 13 September 2023 (the “Program”) for the remaining amount of up to € 250 million of ordinary shares to reduce Exor’s share capital in line with the announcement made on 13 September 2023. The Company will start on 15 April 2024 with a first tranche of ...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

B&S Group: Preview - managing costs. CM.com: Preview 1Q24. Exor: FY23 results show solid 33% YoY NAV per share growth, beating INGF. Fagron: Solid organic performance in 1Q24, driven by Compounding activities

ResearchPool Subscriptions

Get the most out of your insights

Get in touch